SenyaTx

Neuvasq

This company develops Wnt surrogate antibodies to restore blood-brain and blood-retina barriers for patients with vascular retinopathies and neurological disorders.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Angiex

This company develops antibody-drug conjugates for clinicians and pharmaceutical partners to treat solid cancers and vascular diseases.

Neotis

This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.

Northern Biologics

This company develops antibody-based therapeutics targeting the tumour microenvironment to treat patients with cancer and fibrosis.

TigaTx

The company develops engineered immunoglobulin A antibody therapeutics that activate neutrophils to treat patients with cancer and infectious diseases.

Mestag Therapeutics

This company develops antibody therapies targeting fibroblast immunology for patients with cancer and inflammatory diseases.

Calluna Pharma

This clinical-stage company develops monoclonal antibodies to treat inflammatory and fibrotic diseases for patients with conditions like idiopathic pulmonary fibrosis and chronic kidney disease.